ID

23897

Description

Study part: Medication. A phase 2 study to assess safety, reactogenicity and immunogenicity of a booster dose of an investigational vaccination regimen and GSK Biologicals Hib-MenC vaccine (co-administered with Infanrix penta) compared to a booster dose of Menjugate (co-administered with Infanrix hexa).Patient Level Data: Study Listed on ClinicalStudyDataRequest.com. Study ID: 100381, Clinical Study ID: 100381

Keywords

  1. 7/17/17 7/17/17 -
Copyright Holder

GlaxoSmithKline

Uploaded on

July 17, 2017

DOI

To request one please log in.

License

Creative Commons BY-NC 3.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Medication Hib-MenCY-TT-004 BST 003 Neisseria Meningitidis-Haemophilus influenzae type b Vaccine 100381

Medication

  1. StudyEvent: ODM
    1. Medication
MEDICATION
Description

MEDICATION

Alias
UMLS CUI-1
C0013227
Subject number
Description

Subject number

Data type

integer

Alias
UMLS CUI [1]
C2348585
Have any medications/treatments been administered during study period?
Description

medication

Data type

boolean

Alias
UMLS CUI [1]
C0013227
Trade / Generic Name
Description

Trade / Generic Name

Data type

text

Alias
UMLS CUI [1]
C0027365
Medical Indication- Prophylactic
Description

Medical Indication- Prophylactic

Data type

boolean

Alias
UMLS CUI [1,1]
C0199176
UMLS CUI [1,2]
C3146298
UMLS CUI [1,3]
C0013227
Medical Indication
Description

Medical Indication

Data type

text

Alias
UMLS CUI [1]
C2315323
Total daily dose
Description

Total daily dose

Data type

text

Alias
UMLS CUI [1]
C2348070
Route
Description

Route

Data type

text

Alias
UMLS CUI [1]
C0013153
Start date
Description

Start date

Data type

date

Alias
UMLS CUI [1]
C0808070
End date
Description

End date

Data type

date

Alias
UMLS CUI [1]
C0806020
Medication continuing at end of study?
Description

medication ongoing

Data type

boolean

Alias
UMLS CUI [1,1]
C0013227
UMLS CUI [1,2]
C3174772

Similar models

Medication

  1. StudyEvent: ODM
    1. Medication
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
MEDICATION
C0013227 (UMLS CUI-1)
Subject number
Item
Subject number
integer
C2348585 (UMLS CUI [1])
medication
Item
Have any medications/treatments been administered during study period?
boolean
C0013227 (UMLS CUI [1])
Trade / Generic Name
Item
Trade / Generic Name
text
C0027365 (UMLS CUI [1])
Medical Indication- Prophylactic
Item
Medical Indication- Prophylactic
boolean
C0199176 (UMLS CUI [1,1])
C3146298 (UMLS CUI [1,2])
C0013227 (UMLS CUI [1,3])
Medical Indication
Item
Medical Indication
text
C2315323 (UMLS CUI [1])
Total daily dose
Item
Total daily dose
text
C2348070 (UMLS CUI [1])
Route
Item
Route
text
C0013153 (UMLS CUI [1])
Start date
Item
Start date
date
C0808070 (UMLS CUI [1])
End date
Item
End date
date
C0806020 (UMLS CUI [1])
medication ongoing
Item
Medication continuing at end of study?
boolean
C0013227 (UMLS CUI [1,1])
C3174772 (UMLS CUI [1,2])

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial